Abstract
Ormiloxifene is a non steroidal selective estrogen receptor modulator belonging to benzopyran group. Its use as a contraceptive, post coital pill, and as a drug of choice in management of menorrhagia, Dysfunctional Uterine Bleeding is well documented. Duration of treatment and its long term effects have to be evaluated further. We are reporting a rare case of endometrial hyperplasia following unsupervised use of ormiloxifene for prolonged duration, thereby emphasizing follow up of patients on ormiloxifene therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
